Sinopharm Group Co Ltd
HKEX:1099

Watchlist Manager
Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd
HKEX:1099
Watchlist
Price: 20.8 HKD 1.22% Market Closed
Market Cap: 64.9B HKD
Have any thoughts about
Sinopharm Group Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Sinopharm Group Co Ltd stock under the Base Case scenario is 92.62 HKD. Compared to the current market price of 20.8 HKD, Sinopharm Group Co Ltd is Undervalued by 78%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
92.62 HKD
Undervaluation 78%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Sinopharm Group Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Sinopharm Group Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Sinopharm Group Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Sinopharm Group Co Ltd

Provide an overview of the primary business activities
of Sinopharm Group Co Ltd.

What unique competitive advantages
does Sinopharm Group Co Ltd hold over its rivals?

What risks and challenges
does Sinopharm Group Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Sinopharm Group Co Ltd.

Provide P/S
for Sinopharm Group Co Ltd.

Provide P/E
for Sinopharm Group Co Ltd.

Provide P/OCF
for Sinopharm Group Co Ltd.

Provide P/FCFE
for Sinopharm Group Co Ltd.

Provide P/B
for Sinopharm Group Co Ltd.

Provide EV/S
for Sinopharm Group Co Ltd.

Provide EV/GP
for Sinopharm Group Co Ltd.

Provide EV/EBITDA
for Sinopharm Group Co Ltd.

Provide EV/EBIT
for Sinopharm Group Co Ltd.

Provide EV/OCF
for Sinopharm Group Co Ltd.

Provide EV/FCFF
for Sinopharm Group Co Ltd.

Provide EV/IC
for Sinopharm Group Co Ltd.

Show me price targets
for Sinopharm Group Co Ltd made by professional analysts.

What are the Revenue projections
for Sinopharm Group Co Ltd?

How accurate were the past Revenue estimates
for Sinopharm Group Co Ltd?

What are the Net Income projections
for Sinopharm Group Co Ltd?

How accurate were the past Net Income estimates
for Sinopharm Group Co Ltd?

What are the EPS projections
for Sinopharm Group Co Ltd?

How accurate were the past EPS estimates
for Sinopharm Group Co Ltd?

What are the EBIT projections
for Sinopharm Group Co Ltd?

How accurate were the past EBIT estimates
for Sinopharm Group Co Ltd?

Compare the revenue forecasts
for Sinopharm Group Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Sinopharm Group Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Sinopharm Group Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Sinopharm Group Co Ltd compared to its peers.

Compare the P/E ratios
of Sinopharm Group Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Sinopharm Group Co Ltd with its peers.

Analyze the financial leverage
of Sinopharm Group Co Ltd compared to its main competitors.

Show all profitability ratios
for Sinopharm Group Co Ltd.

Provide ROE
for Sinopharm Group Co Ltd.

Provide ROA
for Sinopharm Group Co Ltd.

Provide ROIC
for Sinopharm Group Co Ltd.

Provide ROCE
for Sinopharm Group Co Ltd.

Provide Gross Margin
for Sinopharm Group Co Ltd.

Provide Operating Margin
for Sinopharm Group Co Ltd.

Provide Net Margin
for Sinopharm Group Co Ltd.

Provide FCF Margin
for Sinopharm Group Co Ltd.

Show all solvency ratios
for Sinopharm Group Co Ltd.

Provide D/E Ratio
for Sinopharm Group Co Ltd.

Provide D/A Ratio
for Sinopharm Group Co Ltd.

Provide Interest Coverage Ratio
for Sinopharm Group Co Ltd.

Provide Altman Z-Score Ratio
for Sinopharm Group Co Ltd.

Provide Quick Ratio
for Sinopharm Group Co Ltd.

Provide Current Ratio
for Sinopharm Group Co Ltd.

Provide Cash Ratio
for Sinopharm Group Co Ltd.

What is the historical Revenue growth
over the last 5 years for Sinopharm Group Co Ltd?

What is the historical Net Income growth
over the last 5 years for Sinopharm Group Co Ltd?

What is the current Free Cash Flow
of Sinopharm Group Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Sinopharm Group Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Sinopharm Group Co Ltd

Current Assets 372.2B
Cash & Short-Term Investments 34.4B
Receivables 241.5B
Other Current Assets 96.3B
Non-Current Assets 45.5B
Long-Term Investments 10.6B
PP&E 19.7B
Intangibles 10.1B
Other Non-Current Assets 5.1B
Current Liabilities 281.3B
Accounts Payable 156.6B
Accrued Liabilities 35.2B
Other Current Liabilities 89.5B
Non-Current Liabilities 66.8B
Long-Term Debt 18.5B
Other Non-Current Liabilities 48.2B
Efficiency

Earnings Waterfall
Sinopharm Group Co Ltd

Revenue
590.3B CNY
Cost of Revenue
-543.2B CNY
Gross Profit
47.2B CNY
Operating Expenses
-26.4B CNY
Operating Income
20.8B CNY
Other Expenses
-12.2B CNY
Net Income
8.7B CNY

Free Cash Flow Analysis
Sinopharm Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Sinopharm Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive Free Cash Flow
49/100
Profitability
Score

Sinopharm Group Co Ltd's profitability score is 49/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Sinopharm Group Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Negative Net Debt
Short-Term Solvency
Long-Term Solvency
52/100
Solvency
Score

Sinopharm Group Co Ltd's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Sinopharm Group Co Ltd

Wall Street analysts forecast Sinopharm Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Sinopharm Group Co Ltd is 23.59 HKD with a low forecast of 15.15 HKD and a high forecast of 31.32 HKD.

Lowest
Price Target
15.15 HKD
27% Downside
Average
Price Target
23.59 HKD
13% Upside
Highest
Price Target
31.32 HKD
51% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Sinopharm Group Co Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Sinopharm Group Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Sinopharm Group Co Ltd Logo
Sinopharm Group Co Ltd

Country

China

Industry

Health Care

Market Cap

64.9B HKD

Dividend Yield

4.6%

Description

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2009-09-23. The firm operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Contact

SHANGHAI
Shanghai
Sinopharm Group Building, No. 385, East Longhua Road, Huangpu District
+862123052666.0
www.sinopharmholding.com

IPO

2009-09-23 00:00:00

Employees

108 370

Officers

President & Executive Director
Mr. Wanyong Lian
Chief Financial Officer
Ms. Xiaojuan Li
Secretary to the Board, Company Secretary & Authorised Representative
Mr. Yijian Wu

See Also

Discover More
What is the Intrinsic Value of one Sinopharm Group Co Ltd stock?

The intrinsic value of one Sinopharm Group Co Ltd stock under the Base Case scenario is 92.62 HKD.

Is Sinopharm Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 20.8 HKD, Sinopharm Group Co Ltd is Undervalued by 78%.

Back to Top